CARSGEN-B (02171) Announces Inclusion in Southbound Stock Connect

Bulletin Express03-09

CARsgen Therapeutics Holdings Limited (CARSGEN-B, 02171) disclosed its inclusion in the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect, effective March 9, 2026. According to the announcement, this development allows eligible mainland Chinese investors to directly trade the company's shares through respective stock exchanges.

The announcement highlights that this inclusion signals market recognition of CARSGEN-B’s CAR-T business potential and is expected to provide mainland investors with a more convenient investment channel while enhancing market attention and liquidity. The board of directors advises shareholders and potential investors to exercise caution when dealing in the shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment